Prostate Cancer

1. Front Matter

   Pages i-xiii

   PDF

2. Prostate Cancer Screening in African-American Men

   • Aaron A. Laviana, Peter A. Reisz, Matthew J. Resnick

   Pages 1-19

3. Evaluation and Treatment for Older Men with Elevated PSA

   • Benjamin H. Press, Marc A. Bjurlin, Samir S. Taneja

   Pages 21-41

4. Utilizing Biomarkers in Patients with Prior Negative Prostate Biopsy

   • James T. Kearns, Daniel W. Lin

   Pages 43-52

5. Active Surveillance in African-Americans

   • Samuel L. Washington III, Matthew R. Cooperberg

   Pages 53-58

6. Focal Therapy Versus Surveillance in Intermediate-Risk Cancer

   • Kelly L. Stratton, Daniel Parker

   Pages 59-74

7. Prostate Cancer Treatment Options for Men with Significant Urinary Symptoms and Enlarged Prostates

   • Cary N. Robertson

   Pages 75-80

8. Adjuvant Radiation Therapy for High-Risk Post-prostatectomy Patients

   • William C. Jackson, Daniel E. Spratt, Todd M. Morgan

   Pages 81-99

9. Biochemical Recurrence After Radiation Therapy

   • Christopher Martin, William Lowrance

   Pages 101-119

10. Options After Chemotherapy for Patients with Metastatic, Castration-Resistant Prostate Cancer

    • Daniel J. Lee, Neal D. Shore

    Pages 121-134

11. Evaluation and Treatment for High-Risk Prostate Cancer

    • Lucas W. Dean, Karim A. Touijer

    Pages 135-156

12. High-Intensity Focused Ultrasound (HIFU) Options for High-Risk Prostate Cancer

    • Bruno Nahar, Vivek Venkatramani, Dipen J. Parekh

    Pages 157-168

13. Radical Prostatectomy in the Metastatic Setting

    • Matteo Soligo, Vidit Sharma, R. Jeffrey Karnes

    Pages 169-184

14. Resection of Metastatic Cancer in Castration-Resistant Patients

    • Justin R. Gregg, Chad Reichard, John Davis

    Pages 185-195

15. Back Matter

    Pages 197-202

    PDF

Prostate cancer is the most frequent genitourinary malignancy that garners significant medical and media attention. Over the past decade significant new discoveries have been made that have enabled substantial improvements in screening, diagnosis and management of this disease. Importantly, there has been constant evolution of the best way to treat these patients.

This text will provide a single, comprehensive reference source that incorporates all the latest information regarding prostate cancer. It will serve as an easy reference source for researchers, clinicians, individuals in training, allied health professionals and medical students regarding prostate cancer by focusing on the controversial points of debate. New data regarding PSA screening, prostate cancer biomarkers, diagnostic evaluation techniques, surveillance protocols, and treatment interventions for localized and more advanced disease will be discussed. Gaps in current knowledge and areas for future research will be highlighted. Ongoing important clinical trials which could imminently yield significant new knowledge will be discussed.


Uniquely to all of the above will be the clinical scenario-based format of this text.  For the practicing physician, the prostate cancer screening and treatment situations will hopefully become better understood. We will incorporate key educational concepts in the framework of patient situations with evidence-based discussions of screening, diagnosis, evaluation, and therapeutic management.  To provide even more insight, we plan on a comment section from leaders in the field that will be more “opinion-based” allowing the reader to get access to experienced physicians’ thought processes and practice patterns.


All chapters will be authored by experts in their respective fields and incorporate original figures and illustrations to the extent possible. We anticipate that this book will quickly become the ready reference source for professionals and students in various fields with an interest in the management of a complex and multifaceted disease such as prostate cancer. The book will be comprehensive and encompass the entire the spectrum of prostate cancer. The information will be presented in a succinct and easily understandable manner so as to appeal to both scientists and clinicians.

• Elevated PSA
• Biomarkers
• Active Surveillance
• Focal therapy
• Adjuvant Radiation
• Radiaton Oncology

“This is a good practical resource for anyone interested in, or involved with, prostate cancer management.” (Jay Khastgir, urologynews, urologynews.uk.com, May, 1, 2019)


“This recent addition to the prostate cancer educational forum is an important book for all practicing clinicians who manage prostate cancer. The succinct chapters enable quick review of key topics and controversies in prostate cancer management. By providing these in the setting of clinical vignettes, the authors give clinicians an easier way to understand these nuanced topics.” (Thenappan Chandrasekar, Doody's Book Reviews, August, 2018)


“This textbook is undoubtedly a useful and practical resource for urologists and trainees, involved in the management of prostate cancer.” (Paul Meria, European Urology Today, Vol. 30 (05), October-December, 2018)

• Department of Urologic Surgery and Oncology, Vanderbilt University Medical Center, Nashville, USA

  Sam S. Chang

• Department of Urology, University of Oklahoma Medical Center, Oklahoma City, USA

  Michael S. Cookson

Sam S. Chang, MD, MBAVice-Chair and Patricia and Rodes Hart Professor
Department of Urologic Surgery and Oncology
Vanderbilt Medical Center, MCN A1302, Nashville TN 37232




Michael S. Cookson, MD, MMHC 
Professor & Chair
Department of Urology
Donald D. Albers Chair in Urology
The University of Oklahoma Health Sciences Center & The Stephenson Cancer Center

Policies and ethics